Patents Assigned to College
-
Publication number: 20150288139Abstract: A semiconductor lasing device (10) for emitting radiation at multiple distinct wavelengths, the device (10) comprising an active layer (16) having first portion (20) and a second portion (21), the first and second portions (20, 21) being separated by a Bragg grating (19) extending through the entire depth of the active layer (16), the first portion (20) defining a first lasing cavity (29) for emitting electromagnetic radiation at a first wavelength ?1 and the first and second portions (20, 21) together defining a second lasing cavity (31) for emitting electromagnetic radiation at a second wavelength ?2.Type: ApplicationFiled: September 17, 2013Publication date: October 8, 2015Applicant: University College Cardiff Consultants, Ltd.Inventors: Peter Michael Smowton, Samuel Shutts
-
Patent number: 9149492Abstract: The present invention features methods for stimulating clearance of amyloid beta in microglia, decreasing cognitive decline associated with amyloid pathology, and treating Alzheimer's disease by selectively inhibiting the expression or activity of Acyl-CoA:Cholesterol Acyltransferase 1, but not Acyl-CoA:Cholesterol Acyltransferase 2.Type: GrantFiled: September 11, 2013Date of Patent: October 6, 2015Assignee: Trustees of Dartmouth CollegeInventors: Ta-Yuan Chang, Catherine C. Y. Chang, Yohei Shibuya, Elena Bryleva, Stephanie Murphy, Maximillian A. Rogers
-
Patent number: 9150904Abstract: The invention relates to a method of detecting the coincidence of two biomolecular structures in a solid phase sample, said method comprising: (i) providing a first and a second fusion protein, each fusion protein comprising (a) a detection domain, said detection domain comprising a DNA binding domain; said detection domain capable of binding a cognate specific nucleotide sequence in co-operation with a further detection domain; (b) a recognition domain, said recognition domain capable of binding a target biomolecular structure; and (c) a connector domain; said connector domain being fused at one end to the detection domain and being fused at the other end to the recognition domain; wherein at least two of (a), (b) and (c) are heterologous to one another; wherein the recognition domains of said first and said second fusion proteins are capable of binding to first and second biomolecular structures; (ii) contacting the sample with said first and second fusion proteins; (iii) incubating to allow binding; (iv) rType: GrantFiled: June 23, 2011Date of Patent: October 6, 2015Assignee: King's College LondonInventors: Peter Parker, Michela Perani
-
Patent number: 9150626Abstract: Aggregation is a major cause of the misbehavior of proteins. A system for modifying a protein to create a more stable variant is provided. The method involves identifying non-conserved hydrophobic amino acid residues on the surface of a protein, suitable for mutating to more hydrophilic residues (e.g., charged amino acids). Any number of residues on the surface may be changed to create a variant that is more soluble, resistant to aggregation, has a greater ability to re-fold, and/or is more stable under a variety of conditions. The invention also provides GFP, streptavidin, and GST variants with an increased theoretical net charge created by the inventive technology. Kits are also provided for carrying out such modifications on any protein of interest.Type: GrantFiled: June 1, 2007Date of Patent: October 6, 2015Assignee: President and Fellows of Harvard CollegeInventors: David R. Liu, Kevin John Phillips, Michael S. Lawrence
-
Patent number: 9152321Abstract: Techniques are disclosed for providing a duplicate content mode in touch sensitive computing devices. The duplicate content mode can be used to copy content or objects to a target location using a multiple contact point drag and drop gesture. For example, the duplicate content mode may be used to copy files from a first folder to a second folder. In some cases, the duplicate content mode drag and drop gesture is initiated using multiple contact points, such as two or more fingers, but may transition to a smaller number of contact points, such as one finger, once initiated. In some cases, the user may be able to select additional content after initiating the drag and drop gesture. Once the content has been copied to the target location, the user can then share or organize the content to the users liking.Type: GrantFiled: May 3, 2013Date of Patent: October 6, 2015Assignee: Barnes & Noble College Booksellers, LLCInventors: Kourtny M. Hicks, Amir Mesguich Havilio
-
Patent number: 9150534Abstract: Fluorinated prodrug compounds as can be used for selective streptococcal mevalonate pathway inhibition.Type: GrantFiled: February 28, 2013Date of Patent: October 6, 2015Assignees: Northwestern University, Albert Einstein College of Medicine of Yeshiva UniversityInventors: Richard B. Silverman, Mizuki Watanabe, Soosung Kang, Thomas S. Leyh
-
Patent number: 9150631Abstract: The present invention provides for engineered molecular opsonins that may be used to bind biological pathogens or identify subclasses or specific pathogen species for use in devices and systems for treatment and diagnosis of patients with infectious diseases, blood-borne infections or sepsis. An aspect of the invention provides for mannose-binding lectin (MBL), which is an abundant natural serum protein that is part of the innate immune system. The ability of this protein lectin to bind to surface molecules on virtually all classes of biopathogens (viruses, bacteria, fungi, protozoans) make engineered forms of MBL extremely useful in diagnosing and treating infectious diseases and sepsis.Type: GrantFiled: January 19, 2011Date of Patent: October 6, 2015Assignee: President and Fellows of Harvard CollegeInventors: Michael Super, Jeffrey Charles Way, Donald E. Ingber
-
Patent number: 9150516Abstract: Methods for fluorinating organic compounds are described herein.Type: GrantFiled: April 11, 2012Date of Patent: October 6, 2015Assignee: President and Fellows of Harvard CollegeInventors: Tobias Ritter, Pingping Tang
-
Publication number: 20150275203Abstract: The invention provides novel and versatile classes of riboregulators, including inter alia activating and repressing riboregulators, switches, and trigger and sink RNA, and methods of their use for detecting RNAs in a sample such as a well and in modulating protein synthesis and expression.Type: ApplicationFiled: November 6, 2013Publication date: October 1, 2015Applicants: President and Fellows of Harvard College, Trustees of Boston UniversityInventors: Alexander A. Green, Peng Yin, James J. Collins
-
Publication number: 20150275202Abstract: The present invention discloses generalizable methods of evolving nucleic acids and proteins utilizing continuous directed evolution. The invention discloses methods of passing a nucleic acid from cell to cell in a desired function-dependent manner. The linkage of the desired function and passage of the nucleic acid from cell to cell allows for continuous selection and mutation of the nucleic acid.Type: ApplicationFiled: May 5, 2015Publication date: October 1, 2015Applicant: President and Fellows of Harvard CollegeInventors: David R. Liu, Kevin Michael Esvelt
-
Patent number: 9144573Abstract: The present invention generally relates to prostaglandin transport. More specifically, the invention is directed to compounds that inhibit prostaglandin transport and subsequent COX-2 induction, and methods relating thereto.Type: GrantFiled: July 23, 2012Date of Patent: September 29, 2015Assignees: Albert Einstein College of Medicine of Yeshiva University, New York UniversityInventors: Victor L. Schuster, Yuling Chi, Young-Tae Chang, Jaeki Min
-
Patent number: 9145377Abstract: A compound of formula I wherein Ar1 is a bicyclic aryl or heteroaryl, which may be optionally substituted; X and Y are each independently a group of formula II: -L1-Ar2-L2-Ar3-Q-(CH2)n-NR1R2 L1 and L2 are each independently selected from NR3, C2H2, CH2, —O—, —S— and a bond; Ar2 and Ar3 are independently optionally substituted C5 or C6 aryl or heteroaryl; Q is selected from NH(C?O), NR3, S, O; n is an integer from 1 to 5; R1 and R2 are optionally substituted and are independently hydrogen, C1-7 alkyl, C3-20 heterocyclyl, or C5-20 aryl, or R1 and R2, taken together with the nitrogen atom to which they are attached, form a heterocyclic ring having from 3 to 8 ring atoms; R3 is H or C1-7 alkyl.Type: GrantFiled: April 4, 2012Date of Patent: September 29, 2015Assignee: University College LondonInventors: Stephen Neidle, Caterina Maria Lombardo, Sarah Welsh
-
Patent number: 9146672Abstract: Techniques are disclosed for providing a multidirectional swipe key for a virtual keyboard of a touch sensitive computing device. The multidirectional swipe key can be used to translate one or more swipe gestures started from the key into cursor movement (or directional input). The characteristics of the multidirectional swipe key gestures, such as the swipe direction and/or swipe length, may affect the resulting cursor movement (or directional input). The multidirectional swipe key may be configured such that held swipe gestures cause continual cursor movement (or directional input). The multidirectional swipe key may also be configured such that dragging the gesture to make a longer swipe accelerates cursor movement (or directional input) and vice versa.Type: GrantFiled: April 10, 2013Date of Patent: September 29, 2015Assignee: Barnes & Noble College Booksellers, LLCInventor: Kourtny M. Hicks
-
Publication number: 20150269313Abstract: The present invention relates to methods of storing data using one or more nucleic acids.Type: ApplicationFiled: July 17, 2013Publication date: September 24, 2015Applicant: President and Fellows of Harvard CollegeInventor: George M. Church
-
Publication number: 20150265661Abstract: Provided herein are prebiotic compositions comprising a combination of oligosaccharides such as sialyated oligosaccharides and fusocylated oligosaccharides, and uses thereof in stimulating the proliferation of beneficial intestinal micro biota, for example, of bifidobacteria, and/or in decreasing the abundance of enteric pathogens. The prebiotic compositions can further contain a probiotic, which can be a population of bifidobacteria, lactobacilli, Bacteriodes fragilis, Bacteriodes thetaiotaomicron, Enterococcus faecalis (pro biotic strains thereof), Staphylococcus epidermides, Enterobacter aerogenes, Enterobacter cloacae, or related bacteria having similar functions.Type: ApplicationFiled: March 13, 2013Publication date: September 24, 2015Applicant: Trustees of Boston CollegeInventors: David S. Newburg, Zhuoteng Yu
-
Patent number: 9140606Abstract: An absorption spectroscopy instrument with a light source for providing a beam of light, a modulator to produce a modulated beam of light, a high finesse optical cavity, means for injecting the modulated beam of light off-axis into the high finesse optical cavity and a detector positioned to receive and measure light exiting through said optical cavity. The detector may be a highly sensitive and high bandwidth detector. The modulator may be a one or two-tone modulator having means, such as a plurality of RF synthesizers, for modulating the light source by one or two tones. If one tone of applied modulation is used, the frequency is larger than the absorption bandwidth of the target chemical. In the case where two tones are used, the first frequency is larger than the absorption bandwidth of the target chemical and the second frequency is small relative to the first frequency.Type: GrantFiled: April 19, 2012Date of Patent: September 22, 2015Assignees: President and Fellows of Harvard College, Consiglio Nazionale Delle RicercheInventors: Mark Francis Witinski, Pietro Malara, Gianluca Gagliardi
-
Patent number: 9139809Abstract: The invention is directed compositions and methods related to bacterial cells physically associated with ceramide-like glycolipids. The invention allows for delivery of ceramide-like glycolipid adjuvants directly to the same cells that become infected with a bacterial vaccine. The compositions and methods of the present invention are useful for the prevention and treatment of diseases.Type: GrantFiled: January 8, 2010Date of Patent: September 22, 2015Assignee: Albert Einstein College of Medicine of Yeshiva UniversityInventors: Steven A. Porcelli, Manjunatha M. Venkataswamy
-
Patent number: 9138175Abstract: This invention relates to a system that adaptively compensates for subject motion in real-time in an imaging system. An object orientation marker (30), preferably a retro-grate reflector (RGR), is placed on the head or other body organ of interest of a patient (P) during a scan, such as an MRI scan. The marker (30) makes it possible to measure the six degrees of freedom (x, y, and z-translations, and pitch, yaw, and roll), or “pose”, required to track motion of the organ of interest. A detector, preferably a camera (40), observes the marker (30) and continuously extracts its pose. The pose from the camera (40) is sent to the scanner (120) via an RGR processing computer (50) and a scanner control and processing computer (100), allowing for continuous correction of scan planes and position (in real-time) for motion of the patient (P).Type: GrantFiled: April 28, 2015Date of Patent: September 22, 2015Assignees: The Queen's Medical Center, The University of Hawaii, The Medical College of Wisconsin, Inc., UWM Research Foundation, Inc.Inventors: Thomas Michael Ernst, Thomas Edmund Prieto, Brian Stewart Randall Armstrong
-
Patent number: 9138495Abstract: The present invention relates to bifunctional compounds, the bifunctional compounds for use in molecular imaging and therapy, methods of molecular imaging using the bifunctional compounds and kits including the bifunctional compounds for use molecular imaging. The bifunctional compounds have a tripodal hydroxypyridinone chelating portion and may be conjugated to a targeting group so that the compounds target specific cells or tissues in a subject.Type: GrantFiled: November 11, 2011Date of Patent: September 22, 2015Assignee: King's College LondonInventors: James Russell Ballinger, David Berry, Philip John Blower, Yongmin Ma, Gregory Edgar David Mullen
-
Patent number: 9139625Abstract: The invention provides novel surface coat proteins of Clostridium spp. spores, and nucleic acids encoding such proteins. The invention extends to various uses of these nucleic acids and proteins, as antigens for use in vaccine design and construction, and to vaccines per se, and in diagnostic test kits and methods for the detection of Clostridium spp. infections. In addition, the nucleic acids and proteins can be used as potential targets for therapeutic drugs for the prevention or treatment of Clostridium spp. infections.Type: GrantFiled: May 10, 2012Date of Patent: September 22, 2015Assignee: Royal Holloway and Bedford New CollegeInventors: Simon Michael Cutting, Hong Anh Huynh